🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2026-526613-29-01
Authorised Phase I

Detection of rEPO using Dried Blood Spot (DBS)

2026-526613-29-01 · tracked via the Priya Life Science EU tracker
Sponsor
Consorci Mar Parc De Salut De Barcelona
Sponsor type
Hospital/Clinic/Other health care facility
Therapeutic area
Not possible to specify
Decision date
15/09/2026
Enrollment target
12
Sites
Spain

Condition studied

healthy participants

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2026-526613-29-01 on CTIS ↗ ← All trials in the EU